Tejnaksh Healthcare Stock Falls to 52-Week Low of Rs.15.15

Recent Price Movement and Market Context

On 9 December 2025, Tejnaksh Healthcare’s stock price settled at Rs.15.15, representing the lowest level in the past year. The stock has recorded a consecutive two-day decline, resulting in a cumulative return of -4.13% over this short period. Today’s performance also underperformed its sector by 0.69%, reflecting a relatively weaker showing within the healthcare services segment.

In comparison, the Sensex opened lower by 359.82 points and was trading at 84,654.14, down 0.53% on the day. Despite this, the Sensex remains close to its 52-week high of 86,159.02, just 1.78% away, and is trading above its 50-day moving average, which itself is positioned above the 200-day moving average, signalling a generally bullish trend for the broader market.

Technical Indicators Highlight Weak Momentum

Tejnaksh Healthcare’s share price is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning suggests sustained downward momentum and a lack of short- to medium-term price support. The stock’s 52-week high was Rs.29.50, indicating a substantial decline of nearly 49% from that peak.

Long-Term Performance and Financial Metrics

Over the past year, Tejnaksh Healthcare’s stock has recorded a return of -35.52%, contrasting with the Sensex’s positive return of 3.80% during the same period. This underperformance extends beyond the last year, as the stock has consistently lagged behind the BSE500 benchmark in each of the previous three annual periods.

From a fundamental perspective, the company’s net sales have shown a compound annual growth rate (CAGR) of -1.19% over the last five years, indicating a contraction in revenue. The average return on equity (ROE) stands at 9.52%, which suggests relatively low profitability generated from shareholders’ funds. More recently, the ROE has been recorded at 6.3%, while the price-to-book value ratio is 1.2, reflecting a valuation that is lower than many of its peers.

Profitability has also been under pressure, with profits declining by 25.7% over the past year. Operating cash flow for the year was notably low at Rs.0.38 crore, highlighting limited cash generation from core business activities.

Shareholding and Sector Position

Tejnaksh Healthcare operates within the healthcare services sector, which has seen mixed performance in recent months. The company’s majority shareholding remains with promoters, maintaining a stable ownership structure. Despite this, the stock’s valuation and financial indicators have not aligned favourably with sector averages, contributing to its subdued market performance.

Summary of Key Concerns

The stock’s decline to Rs.15.15 marks a significant milestone, reflecting a combination of subdued revenue growth, limited profitability, and weak cash flow generation. The consistent underperformance relative to benchmarks and peers over multiple years further emphasises the challenges faced by Tejnaksh Healthcare in regaining investor confidence.

While the broader market, as represented by the Sensex, maintains a generally positive trend, Tejnaksh Healthcare’s share price trajectory remains distinctly negative. The stock’s position below all major moving averages underscores the prevailing downward momentum.

Investors and market participants will continue to monitor the company’s financial disclosures and sector developments closely, given the current valuation and performance metrics.

Limited Time Only! Upgrade now and get 1 Year of Stock of the week worth Rs. 14,999 for FREE. Don't miss out on this exclusive offer. Claim Your Free Year →